Cele mai bune TouchPODCAST podcast-uri (2024)

1
touchMDT – Impact of pharmacotherapies for achondroplasia – Discussion 4 19:20

4d ago19:20

19:20

touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia The multidisciplinary team and patient advocate: MFM specialist - Prof. Karin Blakemore Johns Hopkins University School of Med…

1
touchMDT – Monitoring and early treatment initiation - Discussion 3 13:48

4d ago13:48

13:48

touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications The multidisciplinary team and patient advocate: Paediatrician - Prof. Janet Legare Uni…

1
touchMDT – Early recognition of achondroplasia – Discussion 2 16:24

4d ago16:24

16:24

touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications. The multidisciplinary team and patient advocate: Paediatrician - Prof. Janet Legare Univers…

1
touchMDT – MDT management of achondroplasia – Discussion 1 14:14

4d ago14:14

14:14

touchMDT for touchENDOCRINOLOGY Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals The multidisciplinary team: Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke Unive…

1
Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape 32:08

6d ago32:08

32:08

touchEXPERT OPINIONS for touchONCOLOGY In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical pract…

1
touchONCOLOGY: Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer 39:11

23d ago39:11

39:11

touchEXPERT OPINIONS for touchONCOLOGY A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clin…

1
touchIMMUNOLOGY - Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions 32:08

1M ago32:08

32:08

touchEXPERT OPINIONS for touchIMMUNOLOGY Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options. The experts Dr Michael Perch – University of Co…

1
touchRESPIRATORY - Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions 32:08

1M ago32:08

32:08

touchEXPERT OPINIONS for touchRESPIRATORY Three experts share their insights on how to optimize the care of patients with bronchiolitis obliterans syndrome, including the disease pathogenesis and the burden on patients, guideline-directed diagnostic strategies, and current and future treatment options. The experts Dr Michael Perch – University of C…

1
Gastrointestinal oncology experts discuss precision medicine in the treatment of colorectal cancer 43:29

2M ago43:29

43:29

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Juan Manuel O’Connor, a leading expert in colorectal cancer from Argentina, in conversation with Prof. Dr. Francesco Sclafani, a gastrointestinal oncology specialist from Belgium. They respond to questions submitted by the HCP audience and provide their expert insights on the use of precision medi…

1
touchRESPIRATORY - Current treatments and unmet needs in limited-stage small cell lung cancer 15:53

2M ago15:53

15:53

touchFOCUS for touchRESPIRATORY Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients. The expert Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independen…

1
touchONCOLOGY - Current treatments and unmet needs in limited-stage small cell lung cancer 15:53

2M ago15:53

15:53

touchFOCUS for touchONCOLOGY Listen to a medical oncologist share her insights on the current treatments for LS-SCLC and the remaining unmet needs for patients. The expert: Dr Anne Chiang – Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independent …

1
How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 5 13:23

3M ago13:23

13:23

touchMDT for touchNEUROLOGY Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner; they explore the challenges of diagnosing agitation in Alzheimer’s dementia and the importance of a patient-centric multidisciplinary care team that encompasses care partner…

1
Understanding agitation in Alzheimer’s dementia – Discussion 4 11:00

3M ago11:00

11:00

touchMDT for touchNEUROLOGY Listen to an advocate for individuals and families living with Alzheimer’s and other dementias interview a former Alzheimer’s dementia care partner to share personal insights of how agitation impacts not only the person living with dementia but everyone around them. The multidisciplinary team Advocate: Ms Jennifer Pettis…

1
Managing agitation in Alzheimer’s dementia – Discussion 3 14:21

3M ago14:21

14:21

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss best practice management approaches for agitation in Alzheimer’s dementia. The multidisciplinary team Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA Cognitive neurologist: Dr Alireza Atri, Sun City, AZ, USA Nurse practitioner: Ms Susan Scanl…

1
How to recognize and diagnose agitation in Alzheimer’s dementia – Discussion 2 13:19

3M ago13:19

13:19

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss the criteria for diagnosis of agitation in Alzheimer’s dementia; plus, a former care partner shares her insights on the challenges of diagnosis. The multidisciplinary team Geriatric psychiatrist: Prof. George T Grossberg, St Louis, MO, USA Cognitive neurologist:…

1
Understanding agitation in Alzheimer’s dementia – Discussion 1 12:52

3M ago12:52

12:52

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team review the behavioural symptoms of agitation in Alzheimer’s dementia, and hear from a former care partner on how agitation impacts not only the person living with dementia but everyone around them. The multidisciplinary team Geriatric psychiatrist: Prof. George T Grossb…

1
Experts in diabetes discuss the latest developments in basal insulin therapy for type 2 diabetes management 43:38

3M ago43:38

43:38

touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Viswanathan Mohan in conversation with Dr Alice Y Y Cheng. They respond to questions submitted by the HCP audience and provide their expert insights regarding practical considerations for the use of basal insulin therapy in patients with type 2 diabetes, with a focus on the current and future…

1
What’s on the horizon to tackle unmet needs in recurrent metastatic SCCHN? 34:53

4M ago34:53

34:53

touchEXPERT OPINIONS for touchONCOLOGY Three experts share insights into the unmet treatment needs for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the rationale for developing additional immunotherapy-based strategies and targeted therapies, and the latest data and ongoing trials for these investigational app…

1
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs 35:04

4M ago35:04

35:04

touchTALKS for touchONCOLOGY Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs. The expert Dr Reb…

1
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond 17:01

4M ago17:01

17:01

touchFOCUS for touchIMMUNOLOGY Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies. The expert Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Thermo F…

1
Addressing the diagnosis and management of pet allergies in primary care and beyond 16:56

4M ago16:56

16:56

touchFOCUS for touchRESPIRATORY Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management. The expert: Dr Ann-Marie Schoos - Unive…

1
touchHAEMATOLOGY - The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials 34:04

5M ago34:04

34:04

touchEXPERT OPINIONS for touchHAEMATOLOGY Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investi…

1
touchONCOLOGY - The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials 34:04

5M ago34:04

34:04

touchEXPERT OPINIONS for touchONCOLOGY Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigat…

1
touchIMMUNOLOGY - Diagnosing and treating patients with EoE: Tackling the difficulties 35:22

5M ago35:22

35:22

touchEXPERT OPINIONS for touchIMMUNOLOGY Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care. The experts: Dr Efrem Eren, Southampton General Hospital, UK Dr Nirmala Gonsalves, …

1
touchRESPIRATORY - Diagnosing and treating patients with EoE: Tackling the difficulties 35:21

5M ago35:21

35:21

touchEXPERT OPINIONS for touchRESPIRATORY Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care. The experts: Dr Efrem Eren, Southampton General Hospital, UK Dr Nirmala Gonsalves,…

1
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3 14:19

5M ago14:19

14:19

touchMDT for touchIMMUNOLOGY Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Ps…

1
touchMDT – Management of prurigo nodularis – Discussion 2 14:24

5M ago14:24

14:24

touchMDT for touchIMMUNOLOGY Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK This touchPODCAST is for HCPs only. Th…

1
touchMDT – Burden of prurigo nodularis – Discussion 1 13:53

5M ago13:53

13:53

touchMDT for touchIMMUNOLOGY Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK Patient advocate: Ms Sa…

1
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3 14:20

5M ago14:20

14:20

touchMDT for touchDERMATOLOGY Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany P…

1
Is HER2 targeting on the horizon for urothelial carcinoma? 16:16

5M ago16:16

16:16

touchFOCUS for touchONCOLOGY A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice. The expert: Dr…

1
Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease 34:56

5M ago34:56

34:56

touchIN CONVERSATION for touchIMMUNOLOGY Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease. They respond …

1
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL 42:55

6M ago42:55

42:55

touchIN CONVERSATION for touchONCOLOGY Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients w…

1
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy 18:42

6M ago18:42

18:42

touchFOCUS for touchONCOLOGY Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them. The expert: Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, …

1
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma 40:44

6M ago40:44

40:44

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell th…

1
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma 40:45

6M ago40:45

40:45

touchIN CONVERSATION for touchHAEMATOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell…

1
Advances in IOL technology and power calculations: Updates and innovations 17:24

6M ago17:24

17:24

touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Hovanesian answer a series of questions focused on how to effectively manage patients prior to cataract surgery and ensure the most appropriate intraocular lens (IOL) formula is used, including his views on recent advances in IOL technology. The expert: Dr John Hovanesian, University of California…

1
Guideline-based treatment of recurrent/metastatic cervical cancer 35:53

6M ago35:53

35:53

touchEXPERT OPINIONS for touchONCOLOGY Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments. The experts Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA …

1
IgG4-related disease: How to identify, diagnose and treat 48:50

7M ago48:50

48:50

touchSATELLITE SYMPOSIUM for touchIMMUNOLOGY Listen to this touchSATELLITE SYMPOSIUM recorded live in November at the ACR Convergence 2023, in San Diego, CA, USA. Prof. John Stone (USA), the chair for the symposium, is joined by Dr Emanuel Della Torre (Italy) and Dr Arezou Khosroshahi (USA). The first session, led by Prof. John Stone (02:27), focus…

1
Paediatric atopic dermatitis: Evolving strategies for improved management 38:03

7M ago38:03

38:03

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms. The experts Dr Elaine Siegfried - Cardin…

1
Paediatric atopic dermatitis: Evolving strategies for improved management 38:02

7M ago38:02

38:02

touchPANEL DISCUSSION for touchDERMATOLOGY Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms. The experts Dr Elaine Siegfried - Cardi…

1
Optimizing the management of patients with relapsing forms of MS: An update on emerging treatment options 32:04

7M ago32:04

32:04

touchEXPERT OPINIONS for touchNEUROLOGY A leading multiple sclerosis (MS) specialist shares key considerations for a personalized treatment strategy for patients with relapsing forms of MS, and goes on to explore the key role that B cells play in the pathogenesis and progression of MS, including the therapeutic potential of B-cell–targeted agents. …

1
Cataract surgery and ocular comorbidities: Key considerations for intraocular lens choice 35:48

7M ago35:48

35:48

touchEXPERT OPINIONS for touchOPTHALMOLOGY Listen to a leading expert in cataract and refractive surgery discuss the key considerations for intraocular lens selection and management of patients with cataracts and ocular comorbidities, including glaucoma, age-related macular degeneration and diabetic retinopathy. The expert Dr Jennifer Loh – Loh Oph…

1
PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management 50:51

7M ago50:51

50:51

touchCONGRESS for touchONCOLOGY Listen to renowned prostate cancer expert Prof. Oliver Sartor review key data presented at the recent EMSO 2023 congress on new and emerging data that addresses key clinical questions on the use of radiopharmaceuticals in advanced prostate cancer. He also discusses with two additional leading experts, Prof. Francesco…

Podcasturi care merită ascultate

TouchPODCAST

Podcasturi care merită ascultate

Ghid rapid de referință